Correlation Between Viatris and TC BioPharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viatris and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viatris and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viatris and TC BioPharm Holdings, you can compare the effects of market volatilities on Viatris and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viatris with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viatris and TC BioPharm.

Diversification Opportunities for Viatris and TC BioPharm

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Viatris and TCBP is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Viatris and TC BioPharm Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm Holdings and Viatris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viatris are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm Holdings has no effect on the direction of Viatris i.e., Viatris and TC BioPharm go up and down completely randomly.

Pair Corralation between Viatris and TC BioPharm

Given the investment horizon of 90 days Viatris is expected to generate 0.2 times more return on investment than TC BioPharm. However, Viatris is 5.12 times less risky than TC BioPharm. It trades about 0.05 of its potential returns per unit of risk. TC BioPharm Holdings is currently generating about -0.16 per unit of risk. If you would invest  1,157  in Viatris on September 3, 2024 and sell it today you would earn a total of  152.00  from holding Viatris or generate 13.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Viatris  vs.  TC BioPharm Holdings

 Performance 
       Timeline  
Viatris 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Viatris are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Viatris may actually be approaching a critical reversion point that can send shares even higher in January 2025.
TC BioPharm Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TC BioPharm Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Viatris and TC BioPharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viatris and TC BioPharm

The main advantage of trading using opposite Viatris and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viatris position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.
The idea behind Viatris and TC BioPharm Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
CEOs Directory
Screen CEOs from public companies around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences